
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Paget's disease of the breast risk factors
Introduction
Overview
Overview
Common risk factors in the development of Paget’s disease of the breast are female more than male, incidence is higher with increase in age and people of African or Ashkenazi Jewish descent. Personal or family history of breast cancer, environmental exposure to radiation, high temperature and electromagnetic fields. Genetic mutations like BRCA1, BRCA2 4-14% of male breast cancer, klinefelter’s syndrome in males. Mutations in RAD51B, PALB2, CYP17, CHEK2, BRIP1, RAD51C and androgen receptors. BRIP1 and RAD51C have not been seen in male patients. Endocrine-related states with hyperestrogenism such as obesity, exogenous estrogen, testicular dystrophic lesions in males.
Risk Factors
Risk Factors
Common risk factors in the development of Paget’s disease of the breast are.[1][2][3][4]
- Gender female > male
- Age incidence is higher with increase in age
- Personal history of breast cancer
- Family history of breast cancer
- Irradiation
- Genetic mutations
- Endocrine-related states with hyperestrogenism such as:
- obesity
- Exogenous estrogen
- Testicular dystrophic lesions in males
- Environmental exposure to radiation, high temperature and electromagnetic fields.
- Orchitis/epididymitis in males.
- Volatile organic compounds (like: tetrachloroethylene, perchloroethylene, trichloroethylene, dichloroethylene, and benzene)
- Socio-demographic factors such as:
References
References
- β Morandi, Luca; Pession, Annalisa; Marucci, Gian Luca; Foschini, Maria Pia; Pruneri, Giancarlo; Viale, Giuseppe; Eusebi, Vincenzo (2003). “Intraepidermal cells of paget’s carcinoma of the breast can be genetically different from those of the underlying carcinoma”. Human Pathology. 34 (12): 1321β1330. doi:10.1016/S0046-8177(03)00405-2. ISSNΒ 0046-8177.
- β Ruddy, K. J.; Winer, E. P. (2013). “Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship”. Annals of Oncology. 24 (6): 1434β1443. doi:10.1093/annonc/mdt025. ISSNΒ 0923-7534.
- β Ruddy KJ, Winer EP (June 2013). “Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship”. Ann. Oncol. 24 (6): 1434β43. doi:10.1093/annonc/mdt025. PMIDΒ 23425944.
- β Orr, Nick; Lemnrau, Alina; Cooke, Rosie; Fletcher, Olivia; Tomczyk, Katarzyna; Jones, Michael; Johnson, Nichola; Lord, Christopher J; Mitsopoulos, Costas; Zvelebil, Marketa; McDade, Simon S; Buck, Gemma; Blancher, Christine; Trainer, Alison H; James, Paul A; Bojesen, Stig E; Bokmand, Susanne; Nevanlinna, Heli; Mattson, Johanna; Friedman, Eitan; Laitman, Yael; Palli, Domenico; Masala, Giovanna; Zanna, Ines; Ottini, Laura; Giannini, Giuseppe; Hollestelle, Antoinette; Ouweland, Ans M W van den; NovakoviΔ, Srdjan; Krajc, Mateja; Gago-Dominguez, Manuela; Castelao, Jose Esteban; Olsson, HΓ₯kan; Hedenfalk, Ingrid; Easton, Douglas F; Pharoah, Paul D P; Dunning, Alison M; Bishop, D Timothy; Neuhausen, Susan L; Steele, Linda; Houlston, Richard S; Garcia-Closas, Montserrat; Ashworth, Alan; Swerdlow, Anthony J (2012). “Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk”. Nature Genetics. 44 (11): 1182β1184. doi:10.1038/ng.2417. ISSNΒ 1061-4036.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
